INS and type 2 diabetes mellitus: Recently, some new target genes with altered methylation and expression have been identified in pancreatic islets from T2DM by analyzing DNA methylation of 479,927 CpG sites and the transcriptome, indicating that the aberrant DNA methylation could perturb insulin and glucagon secretion [12].